Physician profile
Aurora Gonzalez
NPI 1730139585
$5,392.02
in general payments reported to CMS, 2019-2025
44 companies · $659 in 2025
The $659 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $511 · 2021: $721 · 2022: $829 · 2023: $1,162 · 2024: $649 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354 · Education: $99.99 · Entertainment: $15.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,354.45 |
| Education | $99.99 |
| Entertainment | $15.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $977.69 | 2019-2024 | |
| Astellas Pharma US INC | $538.77 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $463.18 | 2019-2025 | |
| Therapeuticsmd, INC. | $246.14 | 2019-2022 | |
| Myovant Sciences INC. | $243.31 | 2021-2022 | |
| Gynesonics, INC. | $236.69 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $219.52 | 2021-2025 | |
| Exeltis, USA INC. | $215.59 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $186.12 | 2023-2025 | Myfembree |
| Caldera Medical, INC | $156.28 | 2021-2023 | Desara |
| Sage Therapeutics, LLC | $154.08 | 2021-2025 | Zurzuvae |
| Organon LLC | $134.33 | 2022-2025 | Nexplanon, Jada System |
| Millicent US INC | $128.81 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Applied Medical Resources Corporation | $128.64 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $116.01 | 2021-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $113.28 | 2019 | |
| Lupin INC. | $105.70 | 2019-2020 | |
| Evofem Biosciences, INC. | $98.48 | 2021-2024 | |
| Hologic Sales and Service, LLC | $94.10 | 2020-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Acessa Provu System |
| Ethicon US, LLC | $88.23 | 2019-2021 | |
| Baxter Healthcare | $76.26 | 2019-2025 | Tisseel |
| Agile Therapeutics, INC. | $66.31 | 2023-2024 | Twirla |
| Merck Sharp & Dohme LLC | $62.75 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $56.47 | 2022-2023 | Ultomiris |
| Dexcom, INC. | $47.98 | 2025 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $46.89 | 2019-2022 | |
| Aspira Women'S Health INC | $44.04 | 2022-2024 | Ova1 |
| Mylan Pharmaceuticals INC. | $33.78 | 2019-2022 | |
| Allergan, INC. | $32.71 | 2019-2020 | |
| Renovia INC | $29.46 | 2019 | |
| Coloplast Corp | $24.54 | 2021 | |
| Amag Pharmaceuticals, INC. | $24.18 | 2019 | |
| Meditrina | $20.22 | 2023 | |
| Avanos Medical | $20.11 | 2019 | |
| Covidien Lp | $18.18 | 2019 | |
| Avion Pharmaceuticals | $17.82 | 2023 | Balcoltra |
| Vertical Pharmaceuticals, LLC | $17.43 | 2019 | |
| Optinose US, INC. | $17.34 | 2024 | |
| Optumhealth Care Solutions, LLC | $17.34 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Scynexis, INC. | $15.82 | 2021 | |
| Argentum Medical | $15.82 | 2025 | |
| Becton, Dickinson and Company | $14.41 | 2023 | Bd Onclarity |
| Shield Therapeutics INC | $14.10 | 2023 | Accrufer |
| Boston Scientific Corporation | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aurora Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.